|
|
||||||||
Animal: RNA Viruses |
Department of Microbiology and Immunology, The Tokyo Metropolitan Institute for Neuroscience, 2-6 Musashidai, Fuchu-shi, Tokyo 183-8526, Japan1
Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama-cho, Shinjuku-ku, Tokyo 162-8540, Japan2
Department of Laboratory Animal Science, The Tokyo Metropolitan Institute of Medical Science, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8613, Japan3
Author for correspondence: Satoshi Koike. Fax +81 42 321 8678. e-mail koike{at}tmin.ac.jp
In order to determine the influence of poliovirus receptor (PVR) expression on poliovirus cell tropism and neuropathogenesis, two transgenic (tg) mouse models were produced in which PVR was expressed under the transcriptional control of the human PVR gene promoter (hgPVR mice) and the CAG promoter (CAGPVR mice). Then the pathogenicity of poliovirus after intracerebral inoculation of the type 1 Mahoney strain was compared. These showed completely different clinical and pathological changes. In the former, the expression of PVR in neurons in the central nervous system (CNS) confered susceptibility to poliovirus, and a paralytic disease that resembled the human poliomyelitis occurred. In the latter, PVR expression was detected in glial and ependymal cells in addition to the neurons. Paralysis of the limbs and death were rarely observed and mice survived without showing substantial clinical abnormality. Histopathological examination revealed that glial and ependymal cells also became susceptible to poliovirus infection. Poliovirus antigens were mainly detected in ependymal and glial cells and hippocampal neurons near the lateral ventricles in the brain, but were not frequently detected in neurons in the brainstem unlike in the hgPVR mice. The levels of viral antigens and virus recovered from the CNS of CAGPVR mice began to decrease as early as 2 days after inoculation, which suggested induction of a fast immune response. These results suggest that the neuropathogenicity of poliovirus changes markedly depending on the specific expression of the PVR molecule in the CNS.
This article has been cited by other articles:
![]() |
M. Arita, T. Wakita, and H. Shimizu Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity J. Gen. Virol., October 1, 2008; 89(10): 2518 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arita, N. Nagata, T. Sata, T. Miyamura, and H. Shimizu Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J. Gen. Virol., November 1, 2006; 87(Pt 11): 3317 - 3327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ida-Hosonuma, T. Iwasaki, T. Yoshikawa, N. Nagata, Y. Sato, T. Sata, M. Yoneyama, T. Fujita, C. Taya, H. Yonekawa, et al. The Alpha/Beta Interferon Response Controls Tissue Tropism and Pathogenicity of Poliovirus J. Virol., April 1, 2005; 79(7): 4460 - 4469. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Hughes, H. M. Thaker, and V. R. Racaniello Transgenic mouse model for echovirus myocarditis and paralysis PNAS, December 23, 2003; 100(26): 15906 - 15911. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |